Recent news highlights include Clorox shares crossing above the 200-day moving average and Q4 earnings and sales surpassing estimates, supported by GOJO sales. Earnings calls flagged inflation concerns but noted share recovery building. Profit declines were reported for Q4 and fiscal year 2026 despite revenue surpassing estimates.

• Clorox shares crossed above the 200-day moving average, indicating technical strength in the stock price [N1].
• Q4 earnings and sales topped estimates, with GOJO acquisition supporting sales growth [N2].
• The Q4 earnings call highlighted inflationary pressures but noted a building share recovery [N3][N4].
• Q4 and fiscal year 2026 profit declines were reported despite revenues surpassing estimates [N6][N7].
• Clorox held a Q4 earnings conference call on August 3, 2026 [N8].

Clorox's diversified product portfolio across multiple consumer and professional segments, combined with strong brand recognition and market leadership, provides a foundation for resilience amid macroeconomic challenges. The acquisition of GOJO enhances its health and hygiene offerings and expands its B2B footprint, potentially driving recurring demand through installed dispensing systems. The company's ongoing investments in digital transformation, innovation, and sustainability under the IGNITE strategy aim to improve operational efficiency and consumer engagement. Clorox's commitment to dividend payments and recent increase reflects a focus on shareholder value. The company's broad customer base and distribution channels support market reach and sales stability.

Clorox faces risks from macroeconomic uncertainty impacting consumer spending and category slowdowns, which contributed to decreased organic sales and earnings in fiscal 2026. The ERP system implementation caused near-term operational disruptions affecting sales timing. The company is exposed to commodity price volatility, supply chain risks, and inflationary pressures on manufacturing and logistics costs. High customer concentration, particularly reliance on Walmart, presents potential sales risk. Intense competition from national brands, private labels, and retailers may pressure pricing and market share. The company's transformation investments require successful execution to realize anticipated efficiencies. Regulatory, environmental, and geopolitical factors could also impact operations and costs.

Clorox's moat is supported by its portfolio of well-established, trusted brands that hold leading market share positions in their categories, with over 80% of sales from No. 1 or No. 2 ranked brands. The company's broad distribution network across multiple retail channels and geographies, combined with its recent acquisition of GOJO, strengthens its presence in both consumer and professional markets. Its investment in innovation, digital capabilities, and sustainability initiatives under the IGNITE strategy further supports competitive differentiation. Brand equity protection through trademarks and patents, along with ongoing product innovation and marketing, contribute to maintaining its market position. However, the company operates in highly competitive markets with pressure from private labels and other multinational companies.

• Macroeconomic and Consumer Demand Risks: Ongoing macroeconomic uncertainty and changes in consumer shopping behaviors have led to category slowdowns and lower sales, impacting revenue and earnings.
• Operational Disruption from ERP Implementation: The recent ERP system replacement and digital transformation caused near-term disruptions and timing impacts on sales and operations.
• Commodity Price and Supply Chain Volatility: Exposure to fluctuations in raw material, energy, transportation, and labor costs can negatively affect net earnings and cash flow.
• Customer Concentration: Walmart and its affiliates accounted for 26% of consolidated net sales, creating dependency risk on a limited number of large customers.
• Competitive Pressure: The company faces intense competition from national brands, private labels, and retailers, requiring ongoing innovation and marketing investment to maintain market position.
• Execution Risk of Transformation Investments: The $580 million investment in technology and process transformation requires effective implementation to achieve operational efficiencies and growth objectives.

• The Clorox Company is a multinational manufacturer and marketer of consumer and professional products with fiscal year 2026 net sales of $6.7 billion and about 9,200 employees worldwide as of June 30, 2026 [S1].
• Operations span approximately 25 countries or territories, with products sold in about 95 markets primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, drug, pet and military stores, third-party and owned e-commerce channels, and distributors [S1].
• Key consumer brands include Clorox, Pine-Sol, Liquid-Plumr, Poett, Glad, Fresh Step, Kingsford, Hidden Valley, Brita, and Burt's Bees [S1].
• The company also markets professional products under Purell, CloroxPro, and Clorox Healthcare brand names [S1].
• Over 80% of sales come from brands holding No. 1 or No. 2 market share positions in their categories [S1].
• In April 2026, Clorox completed the acquisition of GOJO, adding Purell and health and hygiene solutions, expanding its B2B presence especially in healthcare and institutional markets [S1].
• The IGNITE strategy focuses on innovation, consumer experience, operational transformation, portfolio evolution, and sustainability to drive long-term profitable growth [S1].
• Fiscal year 2026 saw decreases in organic sales and earnings due to macroeconomic uncertainty, category slowdowns, and ERP system implementation timing impacts [S1].
• Diluted net earnings per share decreased 26% compared to prior year, mainly from lower net sales and higher manufacturing and logistics costs, partially offset by lapping a prior divestiture loss [S1].
• The company launched multiple new products and innovations in fiscal 2026 across cleaning, hygiene, personal care, and food categories [S1].
• The Glad business venture agreement with Procter & Gamble expired in January 2026, with Clorox purchasing P&G's 20% interest and retaining exclusive core intellectual property licenses royalty-free [S1].
• Clorox invested approximately $580 million in transformative technologies including ERP replacement and cloud migration, completing core U.S. operations implementation in Q3 fiscal 2026 [S1].
• The company simplified its operating structure in fiscal 2026 to align resources and accelerate execution [S1].
• Sustainability efforts are integrated into the IGNITE strategy, focusing on greenhouse gas reductions and waste minimization [S1].
• Clorox paid $602 million in dividends in fiscal 2026 and announced a 1% dividend increase in July 2026 [S1].
• The company operates four reportable segments: Health and Wellness, Household, Lifestyle, and International, each with defined product categories [S1].
• Health and Wellness includes cleaning, disinfecting, sanitizing, and professional products in the U.S., including Purell and GOJO products [S1].
• Household includes bags and wraps, cat litter, and grilling products in the U.S. [S1].
• Lifestyle includes food, water-filtration, and natural personal care products in the U.S. [S1].
• International segment covers products sold outside the U.S. under various brand names [S1].
• Walmart Stores and affiliates accounted for 26% of consolidated net sales in fiscal 2026, with the top five customers representing about half of sales [S1].
• The company faces intense competition from national brands, private labels, retailers, and competitors in B2B channels, competing on product performance, brand reputation, innovation, and marketing effectiveness [S1].
• Research and development activities focus on product formulation, packaging innovation, manufacturing efficiency, dispensing systems, and digital tools [S1].
• As of March 31, 2026, Clorox had $1.187 billion in cash and equivalents, current assets of $2.651 billion, current liabilities of $3.155 billion, a current ratio of 0.84, and a cash ratio of 0.38 [S2].
• Net income for the quarter ended March 31, 2026, was $187 million [S2].
• Recent news highlights include Clorox shares crossing above the 200-day moving average and Q4 earnings and sales surpassing estimates, supported by GOJO sales [N1][N2].
• Q4 earnings calls flagged inflation concerns but noted share recovery building [N3][N4].
• Q4 and fiscal year 2026 profit declines were reported despite revenue surpassing estimates [N6][N7].
• The company announced a Q4 earnings conference call on August 3, 2026 [N8].